Announcements Trials
Browse Landscape

Status

Not yet recruiting 1

Sponsor Class

OTHER 1

Study Type

Observational 1

Sponsor

Conditions

Polycystic Ovary Syndrome 1Insulin Resistance 1Hyperandrogenism 1Diabetes Mellitus, Type 1 1

Interventions

Observation 21Blood Specimen Collection 20Drug Therapy 13Surveys and Questionnaires 8Surgical Procedures, Operative 8Immunotherapy 7Immune Checkpoint Inhibitors 7Positron Emission Tomography Computed Tomography 5Hematologic Tests 5Watchful Waiting 4Neoadjuvant Therapy 4Fluorodeoxyglucose F18 4Bevacizumab 4darolutamide 3Tyrosine Kinase Inhibitors 3Therapeutics 3Standard of Care 3Radiotherapy 3Indocyanine Green 3Imatinib Mesylate 3Endoscopic Mucosal Resection 3Docetaxel 3Cyclophosphamide 3Capecitabine 3Artificial Intelligence 3tislelizumab 2pertuzumab 2palbociclib 2obinutuzumab 2nilotinib 2

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Not yet recruiting × Observational × Sex Characteristics × Clear all
NCT07490964 2026-04-22

Polycystic Ovary Syndrome in Type 1 Diabetes

Fundacion para la Investigacion Biomedica del Hospital Universitario Ramon y Cajal

Not yet recruiting
60 enrolled

Diabetes Mellitus, Type 1, Insulin Resistance, Polycystic Ovary Syndrome, Hyperandrogenism

Data powered by HemOnc (CC BY 4.0) Colophon âš¡